Top Story

Anxiety, depression predict increased medical use in patients with breast, prostate cancer

Anxiety, depression predict increased medical use in patients with breast, prostate cancer
February 28, 2017

Mood and adjustment disorders, such as anxiety and depression, predicted the number of outpatient visits, hospital admissions and days spent in the hospital for patients with breast or prostate cancer, according to analysis of data from the United States Military Health System scheduled for presentation at the Quality Care Symposium.

Further, between 2007 and 2014, the incidence of mood and adjustment disorders increased from 21% to 28% among women with breast cancer and from 9% to 13% among men with prostate cancer.

In the Journals

CMS plans to implement appropriate use mandate for imaging procedures in 2018

February 27, 2017
When ordering advanced imaging procedures, such as radionuclide imaging, MRI and CT, physicians will soon be required to consult appropriate use criteria using…
Meeting News

In-house specialty pharmacy reduces medical errors, wait time

February 27, 2017
The addition of an in-house specialty pharmacy at a cancer center in Connecticut reduced the amount of time patients waited for oral cancer medications; prevented errors…

Johns Hopkins names clinical director of medical oncology

February 27, 2017
Benjamin Levy, MD, has been named clinical director of medical oncology and medical director of thoracic oncology for Johns Hopkins Kimmel Cancer Center at Sibley…
In the Journals Plus

Cardiac events common after radiotherapy in NSCLC

February 27, 2017
AUTHORS: Wang K, Eblan MJ, Deal AM, Lipner M, Zagar TM, Wang Y, Mavroidis P, Lee CB, Jensen BC, Rosenman JG, Socinski MA, Stinchcombe TE, Marks LB.
More News Headlines »

Immuno-Oncology Forum: Focus on Non-Small Cell Lung Cancer

This activity is supported by educational grants from Bristol-Myers Squibb; Genentech, Inc.; and Merck & Co., Inc.

Lung cancer accounts for 27% of all cancer deaths in the United States, making it the leading cause of cancer…
More »
Meeting News Coverage

VIDEO: Anti-CD19 CAR T cells may offer new option for difficult-to-treat patients with DLBCL

January 5, 2017
More »

The Patient with Castration-resistant Prostate Cancer

No commercial support for this activity.

Castration-resistant prostate cancer (CRPC) is a heterogeneous condition that encompasses a continuum of disease…
More »
Current Issues
View the Current Issue
HemOnc Today